Skip to main content

Tourette Syndrome clinical trials at UC Health
2 in progress, 1 open to eligible people

  • Investigating Circadian Rhythms in Youth With Persistent Tic Disorders

    open to eligible people ages 13-17

    This study examines circadian rhythms and morningness-eveningness preference in youth with Persistent Tic Disorders (PTDs), including Tourette's Disorder (TD); and assesses the effects of wearable short wavelength light therapy on circadian rhythms and tic symptoms.

    at UCLA

  • Ecopipam Treatment of Tourette's Syndrome in Subjects 7-17 Years

    Sorry, in progress, not accepting new patients

    Tourette's Syndrome is a neurological disease characterized by motor and vocal tics. It has been hypothesized that abnormal interactions of dopamine with its receptors may cause the tics. The purpose of this study is to test the hypothesis that a drug (ecopipam) that selectively blocks dopamine D1/D5 receptors can reduce the frequency and severity of the tics.

    at UCLA

Last updated: